Stay updated on Oncolytics Biotech Press Releases
Sign up to get notified when there's something new on the Oncolytics Biotech Press Releases page.

Latest updates to the Oncolytics Biotech Press Releases page
- Check2 days agoChange DetectedUpdated stock pricing data and a new press release headline about pelareorep in colorectal cancer have been added to the Investor Overview, while an earlier price entry and an older FDA milestone press release have been removed.SummaryDifference3%

- Check9 days agoChange DetectedThe stock information updated to show a current price of $0.84 with a change of -$0.014 and -1.63%, replacing the previous values of $0.86, $0.007, and 0.82%.SummaryDifference0.9%

- Check16 days agoChange DetectedOn the Investor Overview page, the NASD:ONCY stock quote values were updated: the price moved from 0.84 to 0.86, the intraday change from 0.041 to 0.007, and the daily percentage change from 5.11% to 0.82%.SummaryDifference1%

- Check23 days agoChange DetectedStock information on the Investor Overview page has been updated to reflect a price of $0.84 and a 5.11% change as of August 18, 2026. A new press release about FDA alignment with the registrational path was added, and an older patent-related press release was removed.SummaryDifference3%

- Check30 days agoChange DetectedStock price updated from $0.80, $0.001 change, and 0.12% to $0.83, $0.034 change, and 4.25%, respectively. These figures represent the latest market activity displayed on the Investor Overview page.SummaryDifference0.9%

- Check37 days agoChange DetectedThe stock quote values on the Investor Overview were updated: the price moved from $0.75 to $0.80, the intraday change from 0 to 0.001, and the percent change from 0.00% to 0.12%. These updates reflect current financial data presented to investors.SummaryDifference0.8%

Stay in the know with updates to Oncolytics Biotech Press Releases
Enter your email address, and we'll notify you when there's something new on the Oncolytics Biotech Press Releases page.